Former KV Pharmaceutical CEO pleads guilty to misbranding drugs
Former KV Pharmaceutical CEO pleads guilty to misbranding drugs
ST. LOUIS (KMOV) – Former KV Pharmaceutical CEO Mark Hermelin pleaded guilty Thursday to two federal charges of misbranding drugs. Hermelin, 69, was sentenced to one month in prison and a one million dollar fine. He will also pay a $900,000 forfeiture to the United States as part of a plea agreement. According to documents filed with the U.S. Attorney’s office, KV manufactured generic …
Published Mar 10, 2011.
Read more: KMOV St. Louis
About the Author
